Body and Mind (XCNQ:BAMM) EBIT : C$-19.43 Mil (TTM As of Jan. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Body and Mind EBIT?

Body and Mind's earnings before interest and taxes (EBIT) for the three months ended in Jan. 2024 was C$-0.97 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jan. 2024 was C$-19.43 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Body and Mind's annualized ROC % for the quarter that ended in Jan. 2024 was -35.95%. Body and Mind's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jan. 2024 was -48.56%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Body and Mind's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jan. 2024 was -81.58%.

Body and Mind EBIT Historical Data

The historical data trend for Body and Mind's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Body and Mind EBIT Chart

Body and Mind Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

EBIT

Get a 7-Day Free Trial

-3.29

-5.85

0.31

-32.69

-21.71

Body and Mind Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
EBIT	Get a 7-Day Free Trial															-1.84	-2.95	-14.02	-1.50	-0.97

Competitive Comparison of Body and Mind's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Body and Mind's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Body and Mind's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Body and Mind's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Body and Mind's EV-to-EBIT falls into.

Body and Mind EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-19.43 Mil.

Body and Mind (XCNQ:BAMM) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Body and Mind's annualized ROC % for the quarter that ended in Jan. 2024 is calculated as:

	ROC % (Q: Jan. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Oct. 2023 )	+	Invested Capital (Q: Jan. 2024 ))	/ count )
=	-4.532 * ( 1 - -57.07% )	/	( (18.411	+	21.19)	/ 2 )
=	-7.1184124	/	19.8005
=	-35.95 %

where

	Invested Capital		(Q: Oct. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	24.003	-	11.352	-	( 1.222	-	max(0, 13.539	-	7.779	+	1.222	))
=	18.411

	Invested Capital		(Q: Jan. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	24.159	-	10.972	-	( 1.953	-	max(0, 15.796	-	7.793	+	1.953	))
=	21.19

Note: The Operating Income data used here is four times the quarterly (Jan. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Body and Mind's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jan. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Jan. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Oct. 2023		Q: Jan. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-3.872	/	( ( (8.153 + max(-5.526, 0))	+	(7.795 + max(-10.912, 0)) )	/	2 )
=	-3.872	/	( ( 8.153	+	7.795 )	/	2 )
=	-3.872	/	7.974
=	-48.56 %

where Working Capital is:

	Working Capital		(Q: Oct. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.875	+	2.885	+	2.369)	-	(11.352	+	0	+	0.303)
=	-5.526

	Working Capital		(Q: Jan. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.046	+	0.864	+	2.138)	-	(10.972	+	0	+	2.988)
=	-10.912

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jan. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Body and Mind's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Jan. 2024 )
	=	-19.425	/	23.810
	=	-81.58 %

Body and Mind EBIT Related Terms

Thank you for viewing the detailed overview of Body and Mind's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Body and Mind (XCNQ:BAMM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Body and Mind Inc (XCNQ:BAMM) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

BMMJ:USA

Address

750-1095 West Pender Street, Vancouver, BC, CAN, V6E 2M6

Website

https://www.bodyandmind.com

Body and Mind Inc is a multi-state cannabis operator, which has retail, distribution, cultivation, and/or processing operations in Nevada, California, Arkansas, Ohio and Illinois. It has developed the marquis lifestyle Body and Mind brand in Nevada with penetration into dispensaries and has expanded its brand and products to dispensaries in California. The Body and Mind brand appeals to a wide range of cannabis consumers with products including flowers, oils, extracts (wax, live resin, ambrosia), and edibles. The Company Operates in Three segments; Wholesale, Retail, and All others. The Majority of revenue is derived from the Retail segment.

Executives

Darren Tindale

Senior Officer

Body and Mind (XCNQ:BAMM) Headlines

From GuruFocus

Books-A-Million: All About Intentions

By Barel Karsan Barel Karsan • 03-28-2011

BooksAMillion Inc. Reports Operating Results (10-Q)

By gurufocus 10qk • 09-09-2010

BooksAMillion Inc. Reports Operating Results (10-Q)

By gurufocus 10qk • 06-10-2010

BooksAMillion Inc. (BAMM) Files Quarterly Report for the Period Ended on 2008-11-01

By gurufocus • 12-15-2008

Books-A-Million - The Anderson Family Turnaround Opportunity

By windplayer13 windplayer13 • 12-06-2014